Related Experiment Video
Updated: Jun 4, 2026

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract
Published on: July 1, 2020
Candida utilis candidaemia in neonatal patients
Amarela Lukić-Grlić1,2, Emilija Mlinarić-Missoni3, Ivančica Škarić2
1Department of Medical Microbiology and Parasitology, University of Zagreb Medical School, Šalata 3, 10 000 Zagreb, Croatia.
Abstract:
In recent years, an evident rise in the frequency of candidaemia caused by non-albicans Candida species has been reported. In this paper we present three cases of clinically manifested candidaemia caused by Candida utilis in neonatal patients hospitalized in the same neonatal intensive care unit within a 6 month period. To the authors' knowledge, only two cases of C. utilis candidaemia have been reported in the literature to date, but neither of these involved newborns. Clinical resolution and elimination of C. utilis from the blood were achieved using liposomal amphotericin B or caspofungin in all patients.
Insights
Candida utilis bloodstream infections (candidaemia) are rare in newborns. This study reports three neonatal cases, successfully treated with antifungal medications, highlighting a potential emerging threat in neonatal intensive care units.
Area of Science:
- Medical Mycology
- Neonatal Infectious Diseases
- Antifungal Resistance
Background:
- Rising incidence of non-albicans Candida bloodstream infections (candidaemia).
- Limited data on Candida utilis infections, particularly in neonates.
- Candida utilis is an emerging opportunistic pathogen.
Observation:
- Three neonates in a single neonatal intensive care unit developed Candida utilis candidaemia within six months.
- This represents a significant increase in reported cases of C. utilis candidaemia, with no prior reports in newborns.
- The infections presented clinically in hospitalized neonatal patients.
Findings:
- Successful clinical resolution and fungal clearance were achieved in all three cases.
- Treatment involved liposomal amphotericin B or caspofungin.
- Candida utilis was eradicated from the bloodstream in all affected infants.
Implications:
- Highlights Candida utilis as a potential cause of neonatal candidaemia.
- Suggests the need for increased surveillance of non-albicans Candida species in neonatal intensive care units.
- Demonstrates effective treatment options for C. utilis infections in vulnerable newborns.
Related Concept Videos
Candidiasis
Cryptococcal Meningitis
Cytomegalovirus Disease

